GH AND IGF-I TREATMENT OF ELDERLY WOMEN
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
批准号:
6055379
负责人:
ANDREW R HOFFMAN
金额:
$25.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-01 至 2001-08-31
关键词:
aging body composition body water clinical research clinical trials estrogens female frail elderly geriatrics hormone regulation /control mechanism hormone therapy human old age (65+) human subject human therapy evaluation insulinlike growth factor lipid metabolism muscle strength osteopenia postmenopause progestins protein metabolism somatotropin women's health
中文摘要
描述(改编自申请人摘要):生长激素(GH)
在正常衰老过程中分泌下降,导致循环功能降低,
胰岛素样生长因子(IGF-1)。 虽然生理
生长激素功能下降的后遗症尚未完全了解,许多
在正常衰老中看到的分解代谢变化,包括骨质减少,肌肉萎缩,
萎缩和运动耐量下降,可能部分是由于
降低GH-IGF-I轴的作用。 与年龄相关的
下丘脑-生长激素-IGF轴的活动因此可能导致
导致老年人福尔斯、骨折和虚弱的分解代谢素质,
这是一种被称为“躯体疾病”的综合征。 以前的工作
已经证明,GH和IGF-I减少脂肪量,增加瘦体
质量和氮的保留,并促进整个身体和骨骼肌网
蛋白质合成
GH和高剂量IGF-1均能增加骨单位的生成率。
然而,低剂量IGF-I可能直接增加成骨细胞功能,
增加骨吸收,因此可以提供一种有用的手段,
增加骨量。 此外,IGF-I可能具有增强情绪的作用,
老人 为了确定延长GH和IGF-I的影响,
治疗和了解其潜在的内分泌机制,
生理效应,三个独立的研究,
GH和IGF-I治疗在躯体疾病中的作用。 在这些
研究,一个主要的重点将放在理解的相互作用,
雌激素/孕激素替代疗法(HRT)和治疗
体细胞死亡 研究1是为期一年的,双盲,随机,
安慰剂对照试验,将探索GH、IGF-I的相互作用
和雌激素/孕酮治疗对身体成分,肌肉力量,
肌肉生长因子合成。 研究II将探索内分泌机制
GH和IGF-I治疗对液体隔室的潜在影响,
详细 这项实验将建立在以前的研究基础上,
表明这两种激素都能引起水的剧烈变化,
胞内空间 第三项研究是一项短期研究,
GH和IGF-1在蛋白质和脂质代谢中的作用,
这些激素在老年妇女中的合成代谢作用。 这项研究将帮助
为研究I中的发现提供了机制基础。这些
这些研究将首次对激素和蛋白质之间的相互作用进行研究,
替代疗法的躯体疾病(生长激素和IGF-I)和更年期
(雌激素和孕酮),并将导致新的药理学方法,
老年人虚弱的治疗
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Growth hormone (GH)
secretion declines during normal aging, resulting in lower circulating
levels of insulin-like growth factor (IGF-1). Although the physiologic
sequelae to decreased somatotrope function are not fully understood, many of
the catabolic changes seen in normal aging, including osteopenia, muscle
atrophy, and decreased exercise tolerance, may in part be caused by the
decreased action of the GH-IGF-I axis. The age-related decline in the
activity of the hypothalamic-somatotrope-IGF axis may thus result in
catabolic diathesis leading to falls, fractures, and frailty in the elderly,
a syndrome complex which has been named "the somatopause". Previous work
has demonstrated that GH and IGF-I decrease fat mass, increase lean body
mass and nitrogen retention, and promote whole body and skeletal muscle net
protein synthesis.
Both GH and high dose IGF-1 increase the birthrate of remodeling osteons.
However, low-dose IGF-I may directly increase osteoblastic function without
increasing bone resorption, and may therefore provide a useful means to
increase bone mass. Moreover, IGF-I may have mood-enhancing effects in the
elderly. In order to determine the effects of prolonged GH and IGF-I
therapy and to understand the endocrine mechanisms underlying their
physiologic effects, three independent investigations into the physiologic
role of GH and IGF-I therapy in the somatopause are proposed. In these
studies, a major emphasis will be placed on understanding the interactions
of estrogen/progestin hormone replacement therapy (HRT) and treatment of the
somatopause. Study 1 is a year long, double-blind, randomized,
placebo-controlled trial which will explore the interactions of GH, IGF-I
and estrogen/progestin therapy on body composition, muscular strength, and
muscle growth factor synthesis. Study II will explore endocrine mechanisms
underlying the effects of GH and IGF-I therapy on fluid compartments in
detail. This experiment will build upon previous studies which unexpectedly
demonstrated that both hormones cause dramatic shifts of water into the
intracellular space. Study III is a short term study that will examine the
role of GH and IGF-1 in protein and lipid metabolism to understand the
anabolic action of these hormones in elderly women. This study will help
provide a mechanistic basis for the finding obtained in Study I. These
studies will provide the first investigation of the interactions of hormone
replacement therapies for the somatopause (GH and IGF-I) and the menopause
(estrogen and progestin) and will lead to novel pharmacologic approaches for
the treatment of frailty in the elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Long Noncoding RNAs in Cancer
-
批准号:10477344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ANDREW R HOFFMAN
-
依托单位:
The Role of Long Noncoding RNAs in Cancer
-
批准号:10015870
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ANDREW R HOFFMAN
-
依托单位:
The Role of Long Noncoding RNAs in Cancer
-
批准号:10216170
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:ANDREW R HOFFMAN
-
依托单位:
Role of Long-Range Chromatin Interactions in Genetic Disease
-
批准号:8511702
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2009
-
负责人:ANDREW R HOFFMAN
-
依托单位:
Role of Long-Range Chromatin Interactions in Genetic Disease
-
批准号:8306162
-
项目类别:
-
资助金额:$35.09万
-
财政年份:2009
-
负责人:ANDREW R HOFFMAN
-
依托单位:
Role of Long-Range Chromatin Interactions in Genetic Disease
-
批准号:7936299
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2009
-
负责人:ANDREW R HOFFMAN
-
依托单位:
Role of Long-Range Chromatin Interactions in Genetic Disease
-
批准号:8111308
-
项目类别:
-
资助金额:$35.09万
-
财政年份:2009
-
负责人:ANDREW R HOFFMAN
-
依托单位:
Novel Androgen Receptor Associated Non-coding RNA's
-
批准号:6773189
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2003
-
负责人:ANDREW R HOFFMAN
-
依托单位:
Novel Androgen Receptor Associated Non-coding RNA's
-
批准号:6682599
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2003
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF I TREATMENT OF ELDERLY WOMEN
-
批准号:6076821
-
项目类别:
-
资助金额:$1.0万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
-
批准号:2516950
-
项目类别:
-
资助金额:$18.39万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF IN TREATMENT OF ELDERLY WOMEN
-
批准号:2052210
-
项目类别:
-
资助金额:$6.86万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
-
批准号:6168139
-
项目类别:
-
资助金额:$20.55万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
-
批准号:3122974
-
项目类别:
-
资助金额:$23.99万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
-
批准号:3122972
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
-
批准号:2769319
-
项目类别:
-
资助金额:$19.08万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF-I TREATMENT OF ELDERLY WOMEN
-
批准号:2052211
-
项目类别:
-
资助金额:$17.72万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
GH AND IGF I TREATMENT OF ELDERLY WOMEN
-
批准号:2052209
-
项目类别:
-
资助金额:$24.94万
-
财政年份:1992
-
负责人:ANDREW R HOFFMAN
-
依托单位:
MECHANISMS OF GENOMIC IMPRINTING
-
批准号:2850499
-
项目类别:
-
资助金额:$21.06万
-
财政年份:1986
-
负责人:ANDREW R HOFFMAN
-
依托单位:
SOMATOMEDIN AND INSULIN REGULATION OF THE PITUITARY
-
批准号:3234375
-
项目类别:
-
资助金额:$17.43万
-
财政年份:1986
-
负责人:ANDREW R HOFFMAN
-
依托单位:
海外基金